Aerie Pharmaceuticals, Inc. (AERI) in Focus: Stock Rises 5.71% - Tale of the Tape
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) was a big mover last session, as the company saw its shares rise nearly 6% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $13.764 to $16.57 in the past one-month time frame, showed a pick-up yesterday at $16.49.
The company has seen 1 positive revision in the past one month, while its Zacks Consensus Estimate of a loss narrowed over the same timeframe, suggesting that more solid trading could be ahead for the company. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
Aerie Pharmaceuticals currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Other attractive players in the healthcare industry include Illumina Inc. (NASDAQ: ILMN) and Gilead Sciences Inc. (NASDAQ: GILD), carrying a Zacks Rank #1 (Strong Buy) and Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) with a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AERIE PHARMACT (NASDAQ: AERI): Get Free Report
GILEAD SCIENCES (NASDAQ: GILD): Free Stock Analysis Report
ILLUMINA INC (NASDAQ: ILMN): Free Stock Analysis Report
ARIAD PHARMA (NASDAQ: ARIA): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The following article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.